A Senate report reveals that the Biden administration was aware of cardiovascular risks related to COVID-19 vaccines early in 2021 but chose not to inform the public for several months.
1. Early Warnings Ignored:
• In February 2021, the CDC's Vaccine Safety Technical Work Group (VaST) reported about nearly 1,000 deaths post-vaccination, indicating many had cardiovascular causes.
• Israel had already informed the CDC about significant cases of myocarditis in young individuals after the Pfizer vaccine.
2. Delayed Public Announcement:
• Despite knowledge of the risks by June 2021, the administration did not update the vaccine labels to warn about myocarditis and pericarditis risks until late that month.
• Senator Ron Johnson criticized the administration for withholding this information from the public, putting young Americans' health at risk.
3. Vaccine Adverse Event Reporting:
• The federal Vaccine Adverse Event Reporting System (VAERS) recorded over 38,600 deaths and numerous other serious cases related to the vaccines.
• CDC research indicated a high verification rate of myocarditis reports following mRNA vaccinations, suggesting under-reporting may be an issue.
4. Other Health Risks Identified:
• A study indicated higher risks of myocarditis post-vaccination, alongside potential links to pericarditis and other serious conditions.
• April 2024 saw the CDC release previously undisclosed reports concerning adverse reactions to the vaccines.
5. Future Safety Trials:
• FDA officials announced plans for new safety trials before recommending additional COVID-19 vaccinations, especially for vulnerable populations.
• Recently, recommendations were withdrawn for healthy children and pregnant women to receive the vaccine, highlighting ongoing changes in policy regarding vaccine safety.
The Senate report underscores significant concerns regarding the transparency of the Biden administration regarding COVID-19 vaccine safety, specifically related to cardiovascular risks identified early on. As studies and reports continue to emerge, discussions surrounding vaccine safety protocols remain critical.
Comments
Post a Comment